Vimarsana
Biggest News Aggregation in the World

Page 49 - Evoke Wealth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evoke Wealth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evoke Wealth Today - Breaking & Trending Today

Holdings Ltd. Thermopylae Buys 64,545 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) Stock - Vimarsana News

Holdings Ltd. Thermopylae Buys 64,545 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) Stock

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Rating) major shareholder Holdings Ltd. Thermopylae acquired 64,545 shares of the firm’s stock in a transaction on Monday, June 6th. The stock was purchased at an average cost of $7.50 per share, with a total value of $484,087.50. Following the completion of the transaction, the insider now owns 55,580,303 […]

Zacks: Analysts Expect Hewlett Packard Enterprise (NYSE:HPE) Will Post Quarterly Sales of $6.83 Billion - Vimarsana News

Zacks: Analysts Expect Hewlett Packard Enterprise (NYSE:HPE) Will Post Quarterly Sales of $6.83 Billion

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Hewlett Packard Enterprise (NYSE:HPE) Receives Average Rating of "Hold" from Brokerages - Vimarsana News

Hewlett Packard Enterprise (NYSE:HPE) Receives Average Rating of "Hold" from Brokerages

Shares of Hewlett Packard Enterprise (NYSE:HPE – Get Rating) have been given a consensus recommendation of “Hold” by the sixteen research firms that are currently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and nine have assigned a buy recommendation […]

Nektar Therapeutics (NASDAQ:NKTR) Expected to Post Earnings of -$0.79 Per Share - Vimarsana News

Nektar Therapeutics (NASDAQ:NKTR) Expected to Post Earnings of -$0.79 Per Share

Brokerages predict that Nektar Therapeutics (NASDAQ:NKTR – Get Rating) will report earnings of ($0.79) per share for the current quarter, Zacks reports. Six analysts have made estimates for Nektar Therapeutics’ earnings. The lowest EPS estimate is ($0.89) and the highest is ($0.66). Nektar Therapeutics reported earnings per share of ($0.68) during the same quarter last […]

SentinelOne, Inc. (NYSE:S) CFO David J. Bernhardt Sells 3,850 Shares - Vimarsana News

SentinelOne, Inc. (NYSE:S) CFO David J. Bernhardt Sells 3,850 Shares

SentinelOne, Inc. (NYSE:S – Get Rating) CFO David J. Bernhardt sold 3,850 shares of the company’s stock in a transaction that occurred on Tuesday, April 19th. The shares were sold at an average price of $36.92, for a total value of $142,142.00. Following the sale, the chief financial officer now directly owns 106,832 shares in […]